Cargando…

Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine

A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Shyam S, Gulli, Giosue, Sharma, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107960/
https://www.ncbi.nlm.nih.gov/pubmed/37077469
http://dx.doi.org/10.1177/20480040231169464
_version_ 1785026724486971392
author Sharma, Shyam S
Gulli, Giosue
Sharma, Pankaj
author_facet Sharma, Shyam S
Gulli, Giosue
Sharma, Pankaj
author_sort Sharma, Shyam S
collection PubMed
description A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issues raised by it regarding the ChAdOx1 nCoV-19 vaccine.
format Online
Article
Text
id pubmed-10107960
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-101079602023-04-18 Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine Sharma, Shyam S Gulli, Giosue Sharma, Pankaj JRSM Cardiovasc Dis Case Report A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issues raised by it regarding the ChAdOx1 nCoV-19 vaccine. SAGE Publications 2023-04-11 /pmc/articles/PMC10107960/ /pubmed/37077469 http://dx.doi.org/10.1177/20480040231169464 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Sharma, Shyam S
Gulli, Giosue
Sharma, Pankaj
Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
title Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
title_full Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
title_fullStr Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
title_full_unstemmed Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
title_short Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
title_sort cerebral venous sinus thrombosis following chadox1 ncov-19 astrazeneca covid-19 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107960/
https://www.ncbi.nlm.nih.gov/pubmed/37077469
http://dx.doi.org/10.1177/20480040231169464
work_keys_str_mv AT sharmashyams cerebralvenoussinusthrombosisfollowingchadox1ncov19astrazenecacovid19vaccine
AT gulligiosue cerebralvenoussinusthrombosisfollowingchadox1ncov19astrazenecacovid19vaccine
AT sharmapankaj cerebralvenoussinusthrombosisfollowingchadox1ncov19astrazenecacovid19vaccine